{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:30:16Z","timestamp":1762176616406},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.pharmthera.2012.08.007","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T14:31:16Z","timestamp":1345213876000},"page":"131-141","source":"Crossref","is-referenced-by-count":16,"title":["The mesenchyme in malignancy: A partner in the initiation, progression and dissemination of cancer"],"prefix":"10.1016","volume":"136","author":[{"given":"Mark A.","family":"Glaire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad M.","family":"El-Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Worthley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0005","doi-asserted-by":"crossref","first-page":"829","DOI":"10.5858\/2002-126-0829-ISOMIN","article-title":"Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps","volume":"126","author":"Adegboyega","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"17","key":"10.1016\/j.pharmthera.2012.08.007_bb0010","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1158\/1078-0432.CCR-0431-03","article-title":"Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas","volume":"10","author":"Adegboyega","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","article-title":"Molecular characterization of the tumor microenvironment in breast cancer","volume":"6","author":"Allinen","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"issue":"6024","key":"10.1016\/j.pharmthera.2012.08.007_bb0030","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.007_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/labinvest.3700654","article-title":"The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses","volume":"87","author":"Bellini","year":"2007","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"5659","key":"10.1016\/j.pharmthera.2012.08.007_bb0045","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","author":"Bhowmick","year":"2004","journal-title":"Science"},{"issue":"7015","key":"10.1016\/j.pharmthera.2012.08.007_bb0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","article-title":"Putting tumours in context","volume":"1","author":"Bissell","year":"2001","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1172\/JCI29159","article-title":"Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury","volume":"117","author":"Brown","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.stem.2008.08.008","article-title":"All MSCs are pericytes?","volume":"3","author":"Caplan","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0075","first-page":"4022","article-title":"A phase IB\/randomized phase II study of gemcitabine (G) plus placebo (P) or vismodegib (V), a hedgehog (Hh) pathway inhibitor, in patients (pts) with metastatic pancreatic cancer (PC): Interim analysis of a University of Chicago phase II consortium study","volume":"30(15_Suppl.)","author":"Catenacci","year":"2012"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.11.024","article-title":"Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway","volume":"21","author":"Cooke","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0085","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.gastro.2007.06.026","article-title":"Carcinogenesis of Helicobacter pylori","volume":"133","author":"Correa","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/dvdy.20554","article-title":"Bone morphogenetic protein signaling pathway plays multiple roles during gastrointestinal tract development","volume":"234","author":"De Santa Barbara","year":"2005","journal-title":"Dev Dyn"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphys.2012.00097","article-title":"Nerve-cancer interactions in the stromal biology of pancreatic cancer","volume":"3","author":"Demir","year":"2012","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrm3112","article-title":"Balancing forces: architectural control of mechanotransduction","volume":"12","author":"DuFort","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6776","key":"10.1016\/j.pharmthera.2012.08.007_bb0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-[kappa]B-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.007_bb0120","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1582-4934.2007.00213.x","article-title":"The myofibroblast: Phenotypic characterization as a prerequisite to understanding its functions in translational medicine","volume":"12","author":"Eyden","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0130","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/ijc.24550","article-title":"The myofibroblast, electron microscopy and cancer research","volume":"125","author":"Eyden","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0135","series-title":"Fawcett: A text book of histology","author":"Fawcett","year":"1994"},{"issue":"20","key":"10.1016\/j.pharmthera.2012.08.007_bb0140","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1158\/0008-5472.CAN-04-2866","article-title":"Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets","volume":"64","author":"Fukino","year":"2004","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.pharmthera.2012.08.007_bb0145","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1001\/jama.297.19.2103","article-title":"Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma","volume":"297","author":"Fukino","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.007_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2011.141","article-title":"Multikinase inhibitors: A new option for the treatment of thyroid cancer","volume":"7","author":"Gild","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.mod.2005.03.003","article-title":"BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system","volume":"122","author":"Goldstein","year":"2005","journal-title":"Mech Dev"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.007_bb0165","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2011.12.058","article-title":"Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice","volume":"142","author":"Gonda","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/138955711795049871","article-title":"Targeting the hedgehog pathway: The development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway","volume":"11","author":"Gould","year":"2011","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0175","first-page":"626","article-title":"Expression pattern of Wnt signaling components in the adult intestine","volume":"129","author":"Gregorieff","year":"2005","journal-title":"YGAST"},{"issue":"28","key":"10.1016\/j.pharmthera.2012.08.007_bb0180","doi-asserted-by":"crossref","first-page":"19864","DOI":"10.1074\/jbc.M800798200","article-title":"Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer","volume":"283","author":"Guo","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35094017","article-title":"Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2","volume":"1","author":"Gupta","year":"2001","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0190","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.007_bb0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jnci\/djj051","article-title":"Gene promoter methylation in prostate tumor-associated stromal cells","volume":"98","author":"Hanson","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"5664","key":"10.1016\/j.pharmthera.2012.08.007_bb0200","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1093587","article-title":"De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine","volume":"303","author":"Haramis","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.007_bb0205","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng1430","article-title":"BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling","volume":"36","author":"He","year":"2004","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2353\/ajpath.2010.090999","article-title":"Epigenetic regulation of myofibroblast differentiation by DNA methylation","volume":"177","author":"Hu","year":"2010","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.08.007_bb0215","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng1596","article-title":"Distinct epigenetic changes in the stromal cells of breast cancers","volume":"37","author":"Hu","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0220","author":"Infinity Pharmaceuticals, Inc. \u2014 News Release"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0225","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.2263","article-title":"Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1","volume":"44","author":"Jaeger","year":"2012","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.007_bb0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrc2346","article-title":"Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer","volume":"8","author":"Jain","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"10.1016\/j.pharmthera.2012.08.007_bb0235","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1158\/0008-5472.CAN-08-1319","article-title":"Global hypomethylation of genomic DNA in cancer-associated myofibroblasts","volume":"68","author":"Jiang","year":"2008","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0240","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: Structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0245","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.090806","article-title":"Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts","volume":"25","author":"Kamiya","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"7069","key":"10.1016\/j.pharmthera.2012.08.007_bb0255","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0260","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/156652409789105570","article-title":"Hedgehog target genes: Mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation","volume":"9","author":"Katoh","year":"2009","journal-title":"Curr Mol Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0265","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ijc.11491","article-title":"Tumor reversion: Correction of malignant behavior by microenvironmental cues","volume":"107","author":"Kenny","year":"2003","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0270","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/dvdy.10382","article-title":"Molecular mechanisms of early gut organogenesis: A primer on development of the digestive tract","volume":"228","author":"Kiefer","year":"2003","journal-title":"Dev Dyn"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0275","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1634\/stemcells.2006-0325","article-title":"Two distinct stem cell lineages in murine bone marrow","volume":"25","author":"Koide","year":"2007","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"39","key":"10.1016\/j.pharmthera.2012.08.007_bb0280","doi-asserted-by":"crossref","first-page":"15418","DOI":"10.1073\/pnas.0707210104","article-title":"Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors","volume":"104","author":"Kosinski","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0285","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1053\/j.gastro.2010.06.014","article-title":"Indian hedgehog regulates intestinal stem cell fate through epithelial\u2013mesenchymal interactions during development","volume":"139","author":"Kosinski","year":"2010","journal-title":"Gastroenterology"},{"issue":"6005","key":"10.1016\/j.pharmthera.2012.08.007_bb0290","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-a","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ng1013","article-title":"Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas","volume":"32","author":"Kurose","year":"2002","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.pharmthera.2012.08.007_bb0300","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1073\/pnas.1114718109","article-title":"Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0305","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1152\/physiolgenomics.00269.2006","article-title":"Deconvoluting the intestine: Molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk","volume":"29","author":"Li","year":"2007","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0310","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-12-0101","article-title":"Cancer-stimulated mesenchymal stem cells create a carcinoma stem-cell niche via prostaglandin E2 signaling","author":"Li","year":"2012","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0315","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ejca.2010.01.010","article-title":"Multikinase inhibitors in thyroid cancer","volume":"46","author":"Licitra","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0320","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.03.037","article-title":"Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice","author":"Manieri","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0325","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.04.047","article-title":"Enteric neuronal density contributes to the severity of intestinal inflammation","volume":"141","author":"Margolis","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.007_bb0330","first-page":"622","article-title":"Morphology and cell proliferation of subepithelial fibroblasts in adult mouse jejunum. I. Structural features","volume":"67","author":"Marsh","year":"1974","journal-title":"YGAST"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.007_bb0335","first-page":"636","article-title":"Morphology and cell proliferation of subepithelial fibroblasts in adult mouse jejunum. II. Radioautographic studies","volume":"67","author":"Marsh","year":"1974","journal-title":"YGAST"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0340","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1053\/j.gastro.2009.03.001","article-title":"The role of the visceral mesoderm in the development of the gastrointestinal tract","volume":"136","author":"McLin","year":"2009","journal-title":"Gastroenterology"},{"issue":"7351","key":"10.1016\/j.pharmthera.2012.08.007_bb0345","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature10212","article-title":"Microenvironmental regulation of stem cells in intestinal homeostasis and cancer","volume":"474","author":"Medema","year":"2011","journal-title":"Nature"},{"issue":"7308","key":"10.1016\/j.pharmthera.2012.08.007_bb0350","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Mendez-Ferrer","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0355","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2008.02.100","article-title":"Folate supplementation and the risk of colonic polyps","volume":"135","author":"Menon","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0360","doi-asserted-by":"crossref","first-page":"G684","DOI":"10.1152\/ajpgi.00474.2010","article-title":"Intestinal myofibroblasts: targets for stem cell therapy","volume":"300","author":"Mifflin","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.007_bb0365","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1073\/pnas.72.9.3585","article-title":"Normal genetically mosaic mice produced from malignant teratocarcinoma cells","volume":"72","author":"Mintz","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.08.007_bb0370","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/0008-5472.CAN-08-0943","article-title":"Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells","volume":"68","author":"Mishra","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1440-1843.2002.00404.x","article-title":"Mesothelial cells: Their structure, function and role in serosal repair","volume":"7","author":"Mutsaers","year":"2002","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0380","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9440(10)64888-2","article-title":"Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model","volume":"160","author":"Mutsaers","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.cellbio.22.010305.104315","article-title":"Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer","volume":"22","author":"Nelson","year":"2006","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0390","first-page":"1","article-title":"T cells control the differentiation of Gr1","author":"Niedermeier","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"38","key":"10.1016\/j.pharmthera.2012.08.007_bb0395","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1073\/pnas.1109493108","article-title":"VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization","volume":"108","author":"O'Connell","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"5933","key":"10.1016\/j.pharmthera.2012.08.007_bb0400","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.pharmthera.2012.08.007_bb0405","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.pharmthera.2012.08.007_bb0410","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4161\/cc.5.15.3112","article-title":"Stromal fibroblasts in cancer: A novel tumor-promoting cell type","volume":"5","author":"Orimo","year":"2006","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.08.007_bb0415","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4161\/cbt.6.4.4255","article-title":"Heterogeneity of stromal fibroblasts in tumors","volume":"6","author":"Orimo","year":"2007","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0420","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.1017547108","article-title":"Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver","volume":"108","author":"\u00d6sterreicher","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","author":"Peinado","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2012.03.002","article-title":"Fibrocytes: Emerging effector cells in chronic inflammation","author":"Peng","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2012.08.007_bb0435","first-page":"G945","article-title":"Subepithelial fibroblast cell lines from different levels of gut axis display regional characteristics","volume":"274","author":"Plateroti","year":"1998","journal-title":"Am J Physiol"},{"issue":"2 Pt 1","key":"10.1016\/j.pharmthera.2012.08.007_bb0440","doi-asserted-by":"crossref","first-page":"C183","DOI":"10.1152\/ajpcell.1999.277.2.C183","article-title":"Myofibroblasts. II. Intestinal subepithelial myofibroblasts","volume":"277","author":"Powell","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0445","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.physiol.70.113006.100646","article-title":"Mesenchymal cells of the intestinal lamina propria","volume":"73","author":"Powell","year":"2011","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0450","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2012.05.013","article-title":"Mesenchymal stem cells and prostaglandins may be critical for intestinal wound repair","volume":"143","author":"Powell","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.007_bb0460","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng.117","article-title":"No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas","volume":"40","author":"Qiu","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0465","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2012.08.007_bb0470","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0475","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1097-0177(2000)9999:9999<::AID-DVDY1047>3.3.CO;2-Y","article-title":"Molecular mechanisms of development of the gastrointestinal tract","volume":"219","author":"Roberts","year":"2000","journal-title":"Dev Dyn"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.007_bb0480","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1242\/dev.121.10.3163","article-title":"Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut","volume":"121","author":"Roberts","year":"1995","journal-title":"Development"},{"issue":"15","key":"10.1016\/j.pharmthera.2012.08.007_bb0485","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1242\/dev.125.15.2791","article-title":"Epithelial\u2013mesenchymal signaling during the regionalization of the chick gut","volume":"125","author":"Roberts","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","author":"Ruffell","year":"2012","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.007_bb0495","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.4049\/jimmunol.177.9.5968","article-title":"Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa","volume":"177","author":"Saada","year":"2006","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2012.08.007_bb0500","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0925-4773(00)00564-5","article-title":"HoxA and HoxB cluster genes subdivide the digestive tract into morphological domains during chick development","volume":"101","author":"Sakiyama","year":"2001","journal-title":"Mech Dev"},{"issue":"19","key":"10.1016\/j.pharmthera.2012.08.007_bb0505","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.yexcr.2011.07.011","article-title":"Boundaries, junctions and transitions in the gastrointestinal tract","volume":"317","author":"San Roman","year":"2011","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0510","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","article-title":"Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast","volume":"145","author":"Scheel","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0515","series-title":"Larsen's human embryology","author":"Schoenwolf","year":"2009"},{"issue":"6077","key":"10.1016\/j.pharmthera.2012.08.007_bb0520","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.1219179","article-title":"A lineage of myeloid cells independent of Myb and hematopoietic stem cells","volume":"336","author":"Schulz","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0525","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diff.2009.08.009","article-title":"Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft","volume":"79","author":"Shaw","year":"2010","journal-title":"Differentiation"},{"issue":"9\u201310","key":"10.1016\/j.pharmthera.2012.08.007_bb0530","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/BF01921739","article-title":"Extracellular matrix components in intestinal development","volume":"51","author":"Simon-Assmann","year":"1995","journal-title":"Experientia"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2012.08.007_bb0535","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000200362","article-title":"Synthesis of basement membrane proteins in the small intestine","volume":"46","author":"Simon-Assmann","year":"1990","journal-title":"Digestion"},{"issue":"40","key":"10.1016\/j.pharmthera.2012.08.007_bb0540","doi-asserted-by":"crossref","first-page":"14842","DOI":"10.1073\/pnas.0606857103","article-title":"Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation","volume":"103","author":"Sneddon","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0545","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4161\/cc.19841","article-title":"Mitochondrial metabolism in cancer metastasis: Visualizing tumor cell mitochondria and the \u201creverse Warburg effect\u201d in positive lymph node tissue","volume":"11","author":"Sotgia","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0550","first-page":"4114","article-title":"The safety of IPI-926, a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients (pts) with metastatic pancreatic cancer","volume":"29(15_Suppl.)","author":"Stephenson","year":"2011"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0555","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.08.007_bb0560","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1242\/dev.127.9.1971","article-title":"The concentric structure of the developing gut is regulated by sonic hedgehog derived from endodermal epithelium","volume":"127","author":"Sukegawa","year":"2000","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0565","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.cell.2007.04.028","article-title":"Neuroepithelial cells supply an initial transient wave of MSC differentiation","volume":"129","author":"Takashima","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.08.007_bb0570","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0012-1606(03)00185-4","article-title":"Wnt signaling during development of the gastrointestinal tract","volume":"259","author":"Theodosiou","year":"2003","journal-title":"Dev Biol"},{"key":"10.1016\/j.pharmthera.2012.08.007_bb0575","series-title":"AACR Meeting","article-title":"A novel HH pathway inhibitor, IPI-926, delays recurrence post-chemotherapy in a primary human SCLC xenograft model","author":"Travaglione","year":"2008"},{"issue":"21","key":"10.1016\/j.pharmthera.2012.08.007_bb0580","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1001\/jama.297.21.2408","article-title":"Folate and cancer\u2014Timing is everything","volume":"297","author":"Ulrich","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0585","first-page":"717","article-title":"Cancer stem cells: Current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"STEM"},{"issue":"19","key":"10.1016\/j.pharmthera.2012.08.007_bb0590","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1101\/gad.1693008","article-title":"A genome-scale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb","volume":"22","author":"Vokes","year":"2008","journal-title":"Genes Dev"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.08.007_bb0595","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1074\/jbc.M109.032672","article-title":"growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells","volume":"285","author":"Walker","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0600","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1086\/504090","article-title":"Total-genome analysis of BRCA1\/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation","volume":"78","author":"Weber","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.08.007_bb0605","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"10.1016\/j.pharmthera.2012.08.007_bb0610","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1242\/dev.02141","article-title":"The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature","volume":"132","author":"Wilm","year":"2005","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0615","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/stem.63","article-title":"Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation","volume":"27","author":"Worthley","year":"2009","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.08.007_bb0620","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/gutjnl-2012-302014","article-title":"Colorectal cancer: A tale of two sides or a continuum?","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0625","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.2278","article-title":"Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid cell maturation and accumulation of CD11b(+)Ly6G(+) immature myeloid cells","volume":"17","author":"Yang","year":"2011","journal-title":"Nat Med"},{"issue":"7211","key":"10.1016\/j.pharmthera.2012.08.007_bb0630","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature07275","article-title":"A paracrine requirement for hedgehog signalling in cancer","volume":"455","author":"Yauch","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.08.007_bb0635","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0022-2143(96)90096-7","article-title":"Neutrophil adherence to and migration across monolayers of human peritoneal mesothelial cells. The role of mesothelium in the influx of neutrophils during peritonitis","volume":"127","author":"Zeillemaker","year":"1996","journal-title":"J Lab Clin Med"},{"issue":"21","key":"10.1016\/j.pharmthera.2012.08.007_bb0640","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.007_bb0645","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10735-007-9078-5","article-title":"The diffuse stellate cell system","volume":"38","author":"Zhao","year":"2007","journal-title":"J Mol Histol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T19:38:08Z","timestamp":1643225888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0163725812001684"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.08.007","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}